Brooks DA - Search Results

1

Neonatal gene therapy with a gamma retroviral vector in mucopolysaccharidosis VI cats.

Ponder KP, O'Malley TM, Wang P, O'Donnell PA, Traas AM, Knox VW, Aguirre GA, Ellinwood NM, Metcalf JA, Wang B, Parkinson-Lawrence EJ, Sleeper MM, Brooks DA, Hopwood JJ, Haskins ME. Ponder KP, et al. Among authors: brooks da. Mol Ther. 2012 May;20(5):898-907. doi: 10.1038/mt.2012.9. Epub 2012 Mar 6. Mol Ther. 2012. PMID: 22395531 Free PMC article.

2

An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum.

Brooks DA, Gibson GJ, Karageorgos L, Hein LK, Robertson EF, Hopwood JJ. Brooks DA, et al. Mol Genet Metab. 2005 Jul;85(3):236-8. doi: 10.1016/j.ymgme.2005.02.008. Epub 2005 Mar 24. Mol Genet Metab. 2005. PMID: 15979036

3

Mutational analysis of mucopolysaccharidosis type VI patients undergoing a phase II trial of enzyme replacement therapy.

Karageorgos L, Brooks DA, Harmatz P, Ketteridge D, Pollard A, Melville EL, Parkinson-Lawrence E, Clements PR, Hopwood JJ. Karageorgos L, et al. Among authors: brooks da. Mol Genet Metab. 2007 Feb;90(2):164-70. doi: 10.1016/j.ymgme.2006.10.008. Epub 2006 Dec 11. Mol Genet Metab. 2007. PMID: 17161971 Clinical Trial.

4

Autologous transplantation of retrovirally transduced bone marrow or neonatal blood cells into cats can lead to long-term engraftment in the absence of myeloablation.

Simonaro CM, Haskins ME, Abkowitz JL, Brooks DA, Hopwood JJ, Zhang J, Schuchman EH. Simonaro CM, et al. Among authors: brooks da. Gene Ther. 1999 Jan;6(1):107-13. doi: 10.1038/sj.gt.3300797. Gene Ther. 1999. PMID: 10341882

5

Laronidase treatment of mucopolysaccharidosis I.

Wraith EJ, Hopwood JJ, Fuller M, Meikle PJ, Brooks DA. Wraith EJ, et al. Among authors: brooks da. BioDrugs. 2005;19(1):1-7. doi: 10.2165/00063030-200519010-00001. BioDrugs. 2005. PMID: 15691212 Review.

6

Enzyme replacement therapy in Mucopolysaccharidosis VI: evidence for immune responses and altered efficacy of treatment in animal models.

Brooks DA, King BM, Crawley AC, Byers S, Hopwood JJ. Brooks DA, et al. Biochim Biophys Acta. 1997 Aug 22;1361(2):203-16. doi: 10.1016/s0925-4439(97)00036-7. Biochim Biophys Acta. 1997. PMID: 9300802 Free article.

7

Immune response to enzyme replacement therapy: 4-sulfatase epitope reactivity of plasma antibodies from MPS VI cats.

Turner CT, Hopwood JJ, Bond CS, Brooks DA. Turner CT, et al. Among authors: brooks da. Mol Genet Metab. 1999 Jul;67(3):194-205. doi: 10.1006/mgme.1999.2859. Mol Genet Metab. 1999. PMID: 10381327

8

Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): a Y210C mutation causes either altered protein handling or altered protein function of N-acetylgalactosamine 4-sulfatase at multiple points in the vacuolar network.

Bradford TM, Litjens T, Parkinson EJ, Hopwood JJ, Brooks DA. Bradford TM, et al. Among authors: brooks da. Biochemistry. 2002 Apr 16;41(15):4962-71. doi: 10.1021/bi0121149. Biochemistry. 2002. PMID: 11939792

9

Iduronate-2-sulphatase protein detection in plasma from mucopolysaccharidosis type II patients.

Parkinson EJ, Muller V, Hopwood JJ, Brooks DA. Parkinson EJ, et al. Among authors: brooks da. Mol Genet Metab. 2004 Jan;81(1):58-64. doi: 10.1016/j.ymgme.2003.11.002. Mol Genet Metab. 2004. PMID: 14728992

10

Immune response to enzyme replacement therapy: clinical signs of hypersensitivity reactions and altered enzyme distribution in a high titre rat model.

Brooks DA, Hopwood JJ, King BM. Brooks DA, et al. Biochim Biophys Acta. 1998 Aug 14;1407(2):163-72. doi: 10.1016/s0925-4439(98)00034-9. Biochim Biophys Acta. 1998. PMID: 9685627 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters